Back
Relmada Therapeutics, Inc. RLMD · Insights
Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States. ... Price4.14
Market Cap441.61 M
Float82.64 M
CountryUS
SectorHealthcare
ExchangeNASDAQ
OverviewFilingsInsightsDilutionNewsTranscriptsInsights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro